CGL5 Cagrilintide 5mg

CGL5 Cagrilintide 5mg is a synthetic, long-acting analogue of the hormone amylin, designed for advanced metabolic and appetite regulation research. Amylin is naturally co-secreted with insulin and plays a key role in controlling post-meal satiety, gastric emptying, and glucagon suppression.

Cagrilintide acts primarily on amylin and calcitonin receptors in the brain, helping researchers study mechanisms of hunger control and energy balance. It has gained attention for its extended half-life and once-weekly activity profile compared to native amylin.

In clinical research, cagrilintide has been evaluated both as a standalone compound and in combination with GLP-1 receptor agonists for enhanced weight-loss outcomes. Its unique mechanism complements incretin-based pathways, making it a valuable tool in obesity and metabolic disorder studies.